MET and lung adenocarcinoma: Authors demonstrated that oleocanthal (at concentrations ranging between 10 and 30 μM) inhibited the HGF-mediated growth and migration in lung adenocarcinoma cells A549 and NCI-H322M through dual targeting of c-Met and COX-1/COX-2, reducing the total and activated c-Met levels and inhibiting COX-1/COX-2 activity (with a higher preference towards COX-2).